Skip to main content
. 2010 Dec 2;79(1):31–57. doi: 10.3797/scipharm.1011-02

Tab. 4.

Activity predicted for the newly designed compounds based on the 11 QSAR models developed in the present work.

Cpd. No. Model A1 Model A2 Model A3 Model A4 Model B1 Model B2 Model B3 Model C1 Model C2 Model C3 Model C4 APA*
N1 4.085 9.362 4.281 3.915 3.213 2.697 3.282 4.900 7.824 3.851 8.831 5.113
N2 4.245 10.777 4.368 3.945 3.818 3.170 3.055 4.497 9.414 4.117 10.525 5.630
N3 3.414 7.474 3.644 3.493 3.533 3.254 3.652 3.971 6.578 3.493 7.281 4.526
N4 3.567 8.805 3.731 3.560 3.278 3.038 3.481 4.041 7.506 3.508 8.386 4.809
N5 3.517 7.759 3.696 3.558 3.594 3.278 3.911 3.982 6.929 3.557 7.759 4.685
N6 3.674 9.155 3.785 3.600 3.558 3.249 3.739 4.011 8.023 3.635 9.012 5.040
N7 3.678 9.276 3.783 3.633 3.592 3.261 3.736 4.110 8.044 3.646 9.053 5.074
N8 3.834 10.614 3.872 3.665 3.526 3.186 3.567 4.067 9.171 3.711 10.338 5.414
N9 3.772 10.125 4.738 4.387 4.727 4.039 2.878 4.405 9.143 4.500 9.643 5.669
N10 3.931 11.553 4.825 4.416 3.462 2.898 2.950 4.368 9.469 4.211 10.740 5.711
N11 3.787 8.678 4.513 4.362 4.300 3.708 3.063 3.858 7.928 4.153 8.685 5.185
N12 3.948 10.130 4.599 4.402 4.330 3.754 2.886 3.936 9.029 4.248 9.979 5.567
N13 3.844 8.990 3.749 3.566 3.494 3.154 3.676 3.816 7.809 3.591 8.747 4.949
N14 3.624 8.496 4.364 4.291 4.113 3.561 3.233 3.668 7.546 3.974 8.492 5.033
N15 3.784 9.786 4.449 4.323 3.239 2.816 3.107 4.069 8.181 3.798 9.347 5.173
*.

average predicted activity.